Hypertension Drugs Market Size

  • Report ID: 2845
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Hypertension Drugs Market Size

Hypertension Drugs Market size was valued at USD 21.85 billion in 2024 and is expected to cross USD 37.11 billion by the end of 2037, registering more than 4.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hypertension drugs is estimated at USD 22.58 billion.

The market is expanding due to an increase in hypertension cases around the world, as it is a condition caused by chronic kidney infection, apnea, and other factors, and is the most common health disorder among the majority of the global population. As a result, the high demand for hypertension drugs is attributed to the high sales volume of hypertension drugs and their available treatment options.

The growing prevalence of insomnia across the globe is believed to fuel market growth. For instance, insomnia is a common sleep disorder that makes it difficult to fall asleep or sometimes causes a person to wake up early. Insomnia is noticed to be interlinked with hypertension and beta-blockers are highly used to treat insomnia heavily across the globe. For instance, it was stated that in every 3 adults across the globe, one of them has insomnia.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2845
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hypertension drugs is estimated at USD 22.58 billion.

The hypertension drugs market size was valued at USD 21.85 billion in 2024 and is expected to cross USD 37.11 billion by the end of 2037, registering more than 4.3% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of hypertension around the world and the growing prevalence of insomnia across the globe will boost the market growth.

North America is predicted to account for the largest share of 30% by 2037, impelled by presence of leading industry players in the region.

The major players in the market include Janssen Global Services, LLC, Atnahs Pharma UK Limited, Sanofi US Services Inc., Pfizer Laboratories Div Pfizer Inc, Merck & Co., Inc., Abbott Laboratories, Daiichi Sankyo Company, Limited, Novartis Pharmaceuticals Corporation, Boehringer Ingelheim group, Lupin Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample